Seeking Alpha

CVS Caremark (CVS +9.2%) shares obviously benefit from its predicted double-digit profit...

CVS Caremark (CVS +9.2%) shares obviously benefit from its predicted double-digit profit increase in 2012 and 30% dividend hike, but it also touts the success of MinuteClinic, a wave of generics that is seen boosting profitability the next several years and customer wins if a contract spat between Walgreen (WAG) and Express Scripts (ESRX) continues into 2012.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs